Aniclindan 75
Aniclindan 75
Authorised
- Clindamycin hydrochloride monohydrate
Product identification
Medicine name:
Aniclindan 75
Active substance:
- Clindamycin hydrochloride monohydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin hydrochloride monohydrate85.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- aniMedica GmbH
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 34170.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 2/09/2024
How useful was this page?:
